"Understanding the constraints and possibilities of nervous system development allows us to consider new experiments and new strategies for therapy development," Dr. Bruijn said. "The most immediate importance of this finding is likely to be in laboratory, where it will help us understand more about how the nervous system may respond when neurons are injured, as they are in ALS."The research was performed by Caroline Rouaux, Ph.D. and Paola Arlotta, Ph.D., of the Department of Stem Cell and Regenerative Biology at Harvard University in Cambridge, Mass. Dr. Arlotta is an Associate Professor at Harvard University and a New York Stem Cell Foundation-Robertson Investigator. Dr. Rouaux received The Milton-Safenowitz Post-Doctoral Fellowship from The ALS Association when in Arlotta's laboratory in 2007 and 2008 and has recently become an Assistant Professor at National Institute of Health and Medical Research (INSERM) in Strasbourg, France where she continues her work in ALS research together with other leaders in the field.
Study Funded By The ALS Association Finds That Neurons Can Be Reprogrammed To Take On New Identities
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.